Financial advisor to Luminex in connection with its sale to DiaSorin
Lead financial and capital markets advisor to POINT Biopharma on its merger with Research Alliance Corp. I, sponsored by RA Capital Management
Exclusive financial advisor to CUNA Mutual Group in connection with its acquisition of Assurant’s Global Preneed business
Financial advisor to the Conflicts Committee of the Board of Directors of Apollo on its conversion to a Full-C Corporation with a One Share / One Vote structure
Financial advisor to KPS Capital Partners on its acquisition of Norsk Hydro's Aluminum Rolling Business
Exclusive financial advisor to Proximus on its acquisition of the remaining minority stakes totaling 42.4% in BICS / TeleSign
Financial advisor to Parallel in connection with its business combination with Ceres Acquisition Corp.
Exclusive financial advisor to Kraft Heinz in connection with the sale of its Planters brand to Hormel Foods Corporation
Independent valuation provider designated by T-Mobile US in connection with its acquisition of Shenandoah Telecommunications Company’s Wireless Assets
Exclusive financial advisor to Luxco on its sale to MGP Ingredients for $475 Million in cash and stock
Exclusive financial advisor to Mesa Biotech on its sale to Thermo Fisher Scientific
Financial advisor to Just Group on the sale of beneficial interest in a ~£540m portfolio of equity release mortgages
Financial advisor to Oxford Immunotec on its sale to PerkinElmer
Financial advisor to Owl Rock on its combination with Dyal Capital Partners and merger with Altimar Acquisition Corporation to form Blue Owl Capital
Exclusive financial advisor to Morgan Stanley Infrastructure Partners in connection with its takeover offer for Tele Columbus